Identification of gene products suppressed by human immunodeficiency virus type 1 infection or gp120 exposure of primary human astrocytes by rapid subtraction hybridization

被引:36
|
作者
Su, ZZ
Kang, DC
Chen, YM
Pekarskaya, O
Chao, W
Volsky, DJ
Fisher, PB
机构
[1] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Urol, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
[4] Columbia Univ Coll Phys & Surg, Dept Neurosurg, New York, NY 10032 USA
[5] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Div Mol Virol, New York, NY USA
关键词
AIDS; gp120; neuropathogenesis; Northern hybridization; reverse;
D O I
10.1080/13550280390201263
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurodegeneration and human immunodeficiency virus type 1 (HIV-1)-associated dementia ( HAD) are the major disease manifestations of HIV-1 colonization of the central nervous system (CNS). In the brain, HIV-1 replicates in microglial cells and infiltrating macrophages and it persists in a low-productive, noncytolytic state in astrocytes. Astrocytes play critical roles in the maintenance of the brain microenvironment, responses to injury, and in neuronal signal transmission, and disruption of these functions by HIV-1 could contribute to HAD. To better understand the potential effects of HIV-1 on astrocyte biology, the authors investigated changes in gene expression using an efficient and sensitive rapid subtraction hybridization approach, RaSH. Primary human astrocytes were isolated from abortus brain tissue, low-passage cells were infected with HIV-1 or mock infected, and total cellular RNAs were isolated at multiple time points over a period of 1 week. This approach is designed to identify gene products modulated early and late after HIV-1 infection and limits the cloning of genes displaying normal cell-cycle fluctuations in astrocytes. By subtracting temporal cDNAs derived from HIV-1-infected astrocytes from temporal cDNAs made from uninfected cells, 10 genes displaying reduced expression in infected cells, termed astrocyte suppressed genes (ASGs), were identified and their suppression was confirmed by Northern blot hybridization. Both known and novel ASGs, not reported in current DNA databases, that are down-regulated by HIV-1 infection are described. Northern blotting confirms suppression of the same panel of ASGs by treatment of astrocytes with recombinant HIV-1 envelope glycoprotein, gp120. These results extend our previous analysis of astrocyte genes induced or enhanced by HIV-1 infection and together they suggest that HIV-1 and viral proteins have profound effects on astrocyte physiology, which may influence their function in the CNS.
引用
收藏
页码:372 / 389
页数:18
相关论文
共 50 条
  • [41] Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein
    Wyatt, R
    Desjardin, E
    Olshevsky, U
    Nixon, C
    Binley, J
    Olshevsky, V
    Sodroski, J
    JOURNAL OF VIROLOGY, 1997, 71 (12) : 9722 - 9731
  • [42] Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120
    Kirchherr, Jennifer L.
    Hamilton, Jennifer
    Lu, Xiaozhi
    Gnanakaran, S.
    Muldoon, Mark
    Daniels, Marcus
    Kasongo, Webster
    Chalwe, Victor
    Mulenga, Chanda
    Mwananyanda, Lawrence
    Musonda, Rosemary M.
    Yuan, Xing
    Montefiori, David C.
    Korber, Bette T.
    Haynes, Barton F.
    Gao, Feng
    VIROLOGY, 2011, 409 (02) : 163 - 174
  • [43] Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways
    Yao, Honghong
    Allen, James E.
    Zhu, Xuhui
    Callen, Shannon
    Buch, Shilpa
    JOURNAL OF NEUROVIROLOGY, 2009, 15 (02) : 164 - 175
  • [44] HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 CHALLENGE OF CHIMPANZEES IMMUNIZED WITH RECOMBINANT ENVELOPE GLYCOPROTEIN GP120
    BERMAN, PW
    GROOPMAN, JE
    GREGORY, T
    CLAPHAM, PR
    WEISS, RA
    FERRIANI, R
    RIDDLE, L
    SHIMASAKI, C
    LUCAS, C
    LASKY, LA
    EICHBERG, JW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) : 5200 - 5204
  • [45] Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: Implications for neuropathogenesis
    Yi, YJ
    Lee, CH
    Liu, QH
    Freedman, BD
    Collman, RG
    JOURNAL OF NEUROVIROLOGY, 2004, 10 : 91 - 96
  • [46] Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways
    Honghong Yao
    James E. Allen
    Xuhui Zhu
    Shannon Callen
    Shilpa Buch
    Journal of NeuroVirology, 2009, 15 : 164 - 175
  • [47] Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: Implications for neuropathogenesis
    Yi Y.
    Lee C.
    Liu Q.-H.
    Freedman B.D.
    Collman R.G.
    Journal of NeuroVirology, 2004, 10 (Suppl 1) : 91 - 96
  • [48] Primary human immunodeficiency virus type 1 infection
    Soogoor M.
    Daar E.S.
    Current HIV/AIDS Reports, 2005, 2 (2) : 55 - 60
  • [49] DIFFERENT PROLIFERATIVE RESPONSE OF HUMAN AND CHIMPANZEE LYMPHOCYTES AFTER CONTACT WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120
    DIRIENZO, AM
    FURLINI, G
    OLIVIER, R
    FERRIS, S
    HEENEY, J
    MONTAGNIER, L
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (01) : 34 - 40
  • [50] MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 AFFECT SENSITIVITY TO NEUTRALIZATION BY GP120 ANTIBODIES
    BACK, NKT
    SMIT, L
    SCHUTTEN, M
    NARA, PL
    TERSMETTE, M
    GOUDSMIT, J
    JOURNAL OF VIROLOGY, 1993, 67 (11) : 6897 - 6902